Ginkgo Bioworks

Ginkgo Bioworks (DNA) is a Boston-based synthetic biology company that operates a cell programming platform for engineering custom organisms. The company serves clients across pharmaceuticals, agriculture, industrial chemicals and consumer products by designing biological systems tailored to specific manufacturing and research needs.

Ginkgo's core asset is its foundry infrastructure, which combines laboratory automation, proprietary software and a large library of genetic parts to enable high-throughput organism engineering. Services include strain improvement, metabolic pathway design and enzyme optimization. The platform approach allows the company to take on diverse projects — from developing bio-based ingredients for food and fragrance to engineering microbes for pharmaceutical production — without building new infrastructure for each application.

The company operates through partnerships and platform agreements with organizations ranging from large pharmaceutical firms to agricultural startups. Rather than manufacturing end products directly, Ginkgo typically licenses its engineered organisms or collects royalties and milestone payments, positioning itself as an enabling technology layer within the broader bioeconomy. This horizontal platform model distinguishes Ginkgo from vertically integrated biotech firms that focus on a single product category.